Tryptophan hydroxylase regulation: Drug-induced modifications that alter serotonin neuronal function

Advances in Experimental Medicine and Biology

Volumn 467, Issue , 2000, Pages 19-27

  Kuhn, D M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; LEVODOPA; METHAMPHETAMINE; QUINONE DERIVATIVE; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME MODIFICATION; ENZYME REGULATION; NERVE FUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; SEROTONINERGIC NERVE CELL;

AMPHETAMINES; ANIMALS; ANTIPARKINSON AGENTS; BRAIN; HUMANS; LEVODOPA; NEURONS; PARKINSON DISEASE; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ANIMALIA;

EID: 0034469647     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (27)

1. Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
2. Evidence for the existence of monoamine-containing neurons in the central nervous system
3. Tryptophan hydroxylase: Cloning and expression of the rat brain enzyme in mammalian cells
4. Expression and deletion mutagenesis of tryptophan hydroxylase fusion proteins: Delineation of the enzyme catalytic core
5. Welcome news about levodopa, but uncertainty remains
6. Methamphetamine-induced decrease in tryptophan hydroxylase activity: Role of 5-hydroxytryptamine transporters
7. Evidence that the large neutral amino acid L-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo
8. Neurotoxicity of amphetamines and their metabolites
9. Mechanisms mediating biogenic amine deficits induced by amphetamine and its congeners
10. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
11. Loss of brain serotonin- and substance P-containing neurons in Parkinsons Disease
12. Neuropathology of immunohistochemically identified brainstem neurons in Parkinsons Disease
13. Dopaminergic transplants alter in vivo activity of tryptophan hydroxylase in the striatum in a rat model of Parkinson's disease
14. Tryptophan hydroxylase inhibition: The mechanism by which p-chlorophenylalanine depletes brain serotonin
15. Inhibition of tryptophan hydroxylase by benserazide and other catechols
16. Inactivation of brain tryptophan hydroxylase by nitric oxide
17. Inactivation of tryptophan hydroxylase by nitric oxide: Enhancement by tetrahydrobiopterin
18. Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: Attack on critical sulfhydryls that spare the enzyme iron center
19. Tryptophan hydroxylase: The role of oxygen, iron, and sulfhydryl groups as determinants of stability and catalytic activity
20. Involvement of serotonin in clinical features of Parkinsons disease and complications of L-DOPA therapy
21. Levodopa toxicity and apoptosis
22. 3,4-Methylenedioxy-methamphetamine-induced acute changes in dopamine transporter function
23. Depression in Parkinson's Disease
24. Inhibition of tryptophan hydroxylase by dopamine and the precursor amino acids
25. Specific detection of quinoproteins by redox-cycling staining
26. In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat
27. In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine